Zoé Léonie Elise van Kempen

25PUBLICATIONS
36CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsInformation modelling, management and ontologiesHaematological tumoursNeurology and neuromuscular diseasesNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 09, 2026
From authorisation to clinical practice: evolution of the use of biological medicines according to the SmPC and guidelines (2006 to 2025).

|May 19, 2026
Reinitiating ocrelizumab with a full 600 mg dose after extended treatment interruption: No increased risk of infusion-related reactions.

|May 08, 2026
Predictors of B-cell repopulation in people with multiple sclerosis treated with ocrelizumab: insights from two large cohorts.

|Feb 04, 2026
Brain atrophy rates vary with age in relapsing-remitting multiple sclerosis.

Sezgi Kaçar, David R van Nederpelt, Julia R Jelgerhuis

|Mar 25, 2025
Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosis.

Liza M Y Gelissen, Alyssa A Toorop, Pien M Schipper

|Nov 04, 2024
Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patients.

Alyssa A Toorop, Mark Hj Wessels, Lynn Boonkamp

Pageof 5

Frequent Collaborators

14 joint publications

Eva Mm Strijbis

7 joint publications

Alyssa A Toorop

5 joint publications

Frederik Barkhof

4 joint publications

Menno M Schoonheim